GO:0071004 U2-type prespliceosome: Components, Assembly and Research Methods

The U2-type prespliceosome (GO:0071004) is a cellular component that sits at the heart of pre-mRNA splicing, the process that removes introns and joins exons to produce mature messenger RNA. It is defined as the spliceosomal complex formed by association of the 5' splice site with the U1 snRNP while the branch point sequence is recognized by the U2 snRNP. This complex includes many proteins in addition to those found in the U1 and U2 snRNPs, and its formation is the point at which a pre-mRNA commits to a given pair of 5' and 3' splice sites. Because splice site selection determines which protein isoform a gene produces, the U2-type prespliceosome is a central node in gene expression regulation. Researchers study GO:0071004 to understand how cells choose between competing splice sites, how mutations in splicing factors cause disease, and how alternative splicing is controlled during development and stress. The complex is also a target for experimental manipulation: knocking down or mutating its components can shift splicing patterns and reveal regulatory networks. In this article we summarize the QuickGO definition, the structure and composition of the U2-type prespliceosome, its molecular mechanism, the genes involved, and the experimental methods used to study it.

According to the QuickGO definition, GO:0071004 (U2-type prespliceosome) is a spliceosomal complex that is formed by association of the 5' splice site with the U1 snRNP, while the branch point sequence is recognized by the U2 snRNP. The prespliceosome includes many proteins in addition to those found in the U1 and U2 snRNPs. Commitment to a given pair of 5' and 3' splice sites occurs at the time of prespliceosome formation. Synonyms include GT-AG prespliceosome, major prespliceosome, mammalian U2-type spliceosomal complex A, and yeast U2-type spliceosomal complex B.

The U2-type prespliceosome is important because it is the earliest committed step in splice site selection for the majority of human introns. Errors in prespliceosome assembly or function can lead to aberrant splicing, which is a common mechanism in cancer, neurodegeneration, and genetic disease. Understanding GO:0071004 therefore provides a framework for interpreting disease-associated mutations in splicing factors and for designing therapies that target splicing.

The following genes encode core and accessory components of the U2-type prespliceosome and related splicing machinery.

Prespliceosome assembly is regulated by the availability and phosphorylation of splicing factors such as U2AF and SF1, and by the activity of splicing kinases and phosphatases. U1-independent splicing pathways can contribute to the regulation of alternative splicing, showing that prespliceosome composition is not fixed.

Mutations in U2AF1 and SF3B1, which are involved in U2-type prespliceosome function, are recurrent in myelodysplastic syndromes and other cancers, leading to altered splice site selection. These mutations can change the balance of prespliceosome assembly and promote oncogenic splicing patterns.

Defects in prespliceosome components can cause aberrant splicing of neuronal genes, contributing to neurodegeneration. U1-independent splicing pathways may modulate these effects by providing alternative routes for intron removal.

Disruption of prespliceosome assembly can affect developmental gene expression programs because commitment to specific splice sites is critical for producing correct protein isoforms. Mutations in core snRNP proteins have been linked to developmental phenotypes.

RNA sequencing can quantify changes in splice site usage and intron retention after perturbation of prespliceosome components. Differential splicing analysis identifies events that depend on U2-type prespliceosome function.

Affinity purification of tagged prespliceosome proteins followed by mass spectrometry reveals interacting partners and complex composition. This approach can identify proteins beyond U1 and U2 snRNPs that associate with the prespliceosome.

In vitro splicing assays using nuclear extracts can monitor prespliceosome assembly and catalysis in a controlled system. These assays allow testing of mutant proteins and RNA substrates.

Fluorescence microscopy and single-molecule imaging can visualize the dynamics of prespliceosome assembly in cells. These methods help determine the order of factor recruitment and the stability of the complex.

Researchers studying U2-type prespliceosome-related genes often need to determine whether a candidate gene is causally involved in splicing regulation or disease. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses directly in relevant cell types.

The U2-type prespliceosome (GO:0071004) is a central cellular component in pre-mRNA splicing, responsible for committing transcripts to specific splice sites. Its assembly involves U1 and U2 snRNPs plus accessory proteins, and its dysfunction is linked to cancer and other diseases. Continued research using CRISPR models and advanced RNA methods will clarify how prespliceosome composition and regulation shape gene expression.